Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%

Stock Markets Nov 25, 2019 05:25PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Healthcare and Industrials sectors led shares higher.

At the close in NYSE, the Dow Jones Industrial Average gained 0.68% to hit a new all time high, while the S&P 500 index added 0.75%, and the NASDAQ Composite index gained 1.32%.

The best performers of the session on the Dow Jones Industrial Average were UnitedHealth Group Incorporated (NYSE:UNH), which rose 2.11% or 5.83 points to trade at 282.67 at the close. Meanwhile, Intel Corporation (NASDAQ:INTC) added 2.08% or 1.20 points to end at 58.81 and Dow Inc (NYSE:DOW) was up 1.86% or 1.01 points to 55.20 in late trade.

The worst performers of the session were Exxon Mobil Corp (NYSE:XOM), which fell 0.66% or 0.46 points to trade at 68.91 at the close. McDonald’s Corporation (NYSE:MCD) declined 0.65% or 1.25 points to end at 191.89 and Verizon Communications Inc (NYSE:VZ) was down 0.62% or 0.37 points to 59.38.

The top performers on the S&P 500 were L Brands Inc (NYSE:LB) which rose 6.44% to 19.17, Tiffany & Co (NYSE:TIF) which was up 6.17% to settle at 133.25 and Incyte Corporation (NASDAQ:INCY) which gained 5.94% to close at 94.00.

The worst performers were Comcast Corp (NASDAQ:CMCSA) which was down 3.24% to 43.35 in late trade, Jacobs Engineering Group Inc (NYSE:JEC) which lost 2.82% to settle at 90.75 and JM Smucker Company (NYSE:SJM) which was down 2.37% to 105.83 at the close.

The top performers on the NASDAQ Composite were Sorrento Therape (NASDAQ:SRNE) which rose 94.38% to 3.11, Janone Inc (NASDAQ:JAN) which was up 54.51% to settle at 3.9400 and Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) which gained 51.61% to close at 0.4700.

The worst performers were Cymabay Therapeu (NASDAQ:CBAY) which was down 75.86% to 1.340 in late trade, La Jolla Pharmaceutical Co (NASDAQ:LJPC) which lost 53.58% to settle at 2.59 and Adamis Pharma (NASDAQ:ADMP) which was down 50.96% to 0.62 at the close.

Rising stocks outnumbered declining ones on the New York Stock Exchange by 2057 to 783 and 91 ended unchanged; on the Nasdaq Stock Exchange, 2034 rose and 626 declined, while 68 ended unchanged.

Shares in Tiffany & Co (NYSE:TIF) rose to 52-week highs; up 6.17% or 7.74 to 133.25. Shares in Incyte Corporation (NASDAQ:INCY) rose to 52-week highs; up 5.94% or 5.27 to 94.00. Shares in Cymabay Therapeu (NASDAQ:CBAY) fell to 3-years lows; losing 75.86% or 4.210 to 1.340. Shares in La Jolla Pharmaceutical Co (NASDAQ:LJPC) fell to 5-year lows; losing 53.58% or 2.99 to 2.59.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 3.81% to 11.87 a new 52-week low.

Gold Futures for February delivery was down 0.58% or 8.55 to $1461.95 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 0.24% or 0.14 to hit $57.91 a barrel, while the February Brent oil contract unchanged 0.00% or 0.00 to trade at $62.53 a barrel.

EUR/USD was down 0.01% to 1.1012, while USD/JPY rose 0.03% to 108.94.

The US Dollar Index Futures was up 0.04% at 98.218.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%
 

Related Articles

Former Deutsche Bank co-CEO Anshu Jain dies
Former Deutsche Bank co-CEO Anshu Jain dies By Reuters - Aug 13, 2022 11

(Reuters) -Anshu Jain, a top finance executive best known for helping German lender Deutsche Bank AG (NYSE:DB) take on the largest Wall Street firms, died overnight on Saturday...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Azam Khan
Azam Khan Nov 25, 2019 5:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now this news seems to good at least it's not about trade war. This is what I expect
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email